Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD-1211 in Opioid-Induced Constipation
NCT01333540Phase 2Completed
- Sponsor
- Glycyx Therapeutics
- Start
- May 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axelopran in opioid-induced constipation (OIC), sponsored by Glycyx Therapeutics. Started May 2011; status: completed.
02
Drugs
axelopran
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01333540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333540.